Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

ClinicalTrials.gov ID: NCT00141271

Public ClinicalTrials.gov record NCT00141271. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression

Study identification

NCT ID
NCT00141271
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
536 participants

Conditions and interventions

Interventions

  • Geodon (Ziprasidone) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Jan 31, 2008
Completion
Jan 31, 2008
Last update posted
Mar 24, 2021

2005 – 2008

United States locations

U.S. sites
72
U.S. states
25
U.S. cities
63
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35209
Pfizer Investigational Site Dana Point California 92629
Pfizer Investigational Site La Mesa California 91942
Pfizer Investigational Site Laguna Hills California 92653
Pfizer Investigational Site Oceanside California 92056
Pfizer Investigational Site Orange California 92868
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site Santa Ana California 92705
Pfizer Investigational Site Torrance California 90505
Pfizer Investigational Site Fort Lauderdale Florida 33319
Pfizer Investigational Site Gainesville Florida 32607
Pfizer Investigational Site Hialeah Florida 33016
Pfizer Investigational Site Jacksonville Florida 32216
Pfizer Investigational Site North Miami Florida 33161
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Winter Park Florida 32789
Pfizer Investigational Site Atlanta Georgia 30308
Pfizer Investigational Site Maywood Illinois 60153
Pfizer Investigational Site Naperville Illinois 60563
Pfizer Investigational Site Schaumburg Illinois 60194
Pfizer Investigational Site Greenwood Indiana 46143
Pfizer Investigational Site Lafayette Indiana 47905
Pfizer Investigational Site Prarie Village Kansas 66206
Pfizer Investigational Site New Orleans Louisiana 70114
Pfizer Investigational Site Shreveport Louisiana 71101
Pfizer Investigational Site Shreveport Louisiana 71105
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Worcester Massachusetts 01605
Pfizer Investigational Site Minneapolis Minnesota 55454
Pfizer Investigational Site Flowood Mississippi 39232
Pfizer Investigational Site St Louis Missouri 63128
Pfizer Investigational Site St Louis Missouri 63144
Pfizer Investigational Site Omaha Nebraska 68131
Pfizer Investigational Site Las Vegas Nevada 89102
Pfizer Investigational Site Clementon New Jersey 08021
Pfizer Investigational Site Toms River New Jersey 08755
Pfizer Investigational Site New York New York 10021
Pfizer Investigational Site Staten Island New York 10305
Pfizer Investigational Site Cincinnati Ohio 45267-0001
Pfizer Investigational Site Cleveland Ohio 44106
Pfizer Investigational Site Cleveland Ohio 44113
Pfizer Investigational Site Mayfield Ohio 44143
Pfizer Investigational Site Oklahoma City Oklahoma 73118
Pfizer Investigational Site Philadelphia Pennsylvania 19131
Pfizer Investigational Site Philadelphia Pennsylvania 19149
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Charleston South Carolina 29425
Pfizer Investigational Site Columbia South Carolina 29201
Pfizer Investigational Site Memphis Tennessee 38119
Pfizer Investigational Site Nashville Tennessee 37203-1515
Pfizer Investigational Site Bellaire Texas 77401
Pfizer Investigational Site Dallas Texas 75216
Pfizer Investigational Site Dallas Texas 75234
Pfizer Investigational Site DeSoto Texas 75115
Pfizer Investigational Site Galveston Texas 77555-0188
Pfizer Investigational Site Houston Texas 77555
Pfizer Investigational Site Irving Texas 75062
Pfizer Investigational Site Plano Texas 75093
Pfizer Investigational Site Richardson Texas 75080
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site San Antonio Texas 78284-7792
Pfizer Investigational Site Wichita Falls Texas 76309
Pfizer Investigational Site Arlington Virginia 22201
Pfizer Investigational Site Falls Church Virginia 22041
Pfizer Investigational Site Richmond Virginia 23229
Pfizer Investigational Site Richmond Virginia 23230
Pfizer Investigational Site Virginia Beach Virginia 23452
Pfizer Investigational Site Kirkland Washington 98033
Pfizer Investigational Site Milwaukee Wisconsin 53226
Pfizer Investigational Site Milwaukee Wisconsin 53227
Pfizer Investigational Site West Allis Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00141271, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2021 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00141271 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →